These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 16913826)

  • 21. [Pharmacological basis of antihypertensive drug therapy].
    Kolck UW; Zaugg CE; Erne P
    Praxis (Bern 1994); 2004 May; 93(20):847-56. PubMed ID: 15195836
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Utilization of antihypertensive drugs in obesity-related hypertension: a retrospective observational study in a cohort of patients from Southern Italy.
    Cataldi M; di Geronimo O; Trio R; Scotti A; Memoli A; Capone D; Guida B
    BMC Pharmacol Toxicol; 2016 Mar; 17():9. PubMed ID: 26980335
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development and trends in the drug treatment of essential hypertension.
    van Zwieten PA
    J Hypertens Suppl; 1992 Dec; 10(7):S1-12. PubMed ID: 1363322
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk for incident atrial fibrillation in patients who receive antihypertensive drugs: a nested case-control study.
    Schaer BA; Schneider C; Jick SS; Conen D; Osswald S; Meier CR
    Ann Intern Med; 2010 Jan; 152(2):78-84. PubMed ID: 20083826
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reversal of left ventricular hypertrophy in essential hypertension. A meta-analysis of randomized double-blind studies.
    Schmieder RE; Martus P; Klingbeil A
    JAMA; 1996 May; 275(19):1507-13. PubMed ID: 8622227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HYT-hypertension in Turkey: a cross-sectional survey on blood pressure control with calcium channel blockers alone or combined with other antihypertensive drugs.
    Seravalle G; Koylan N; Nalbantgil I; Caglar N; Quarti-Trevano F; Makel W; Grassi G; Fici F
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):165-72. PubMed ID: 25900022
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000.
    Al Khaja KA; Sequeira RP
    Pharmacoepidemiol Drug Saf; 2006 Oct; 15(10):741-8. PubMed ID: 16342299
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal protection in hypertensive patients: selection of antihypertensive therapy.
    Wenzel RR
    Drugs; 2005; 65 Suppl 2():29-39. PubMed ID: 16398060
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel combinations in the treatment of hypertension.
    Sica DA
    Minerva Urol Nefrol; 2005 Sep; 57(3):129-39. PubMed ID: 15986012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Characteristics of treated hypertension in incident hemodialysis and peritoneal dialysis patients.
    Griffith TF; Chua BS; Allen AS; Klassen PS; Reddan DN; Szczech LA
    Am J Kidney Dis; 2003 Dec; 42(6):1260-9. PubMed ID: 14655199
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angiotensin receptor blockers for management of hypertension.
    Catanzaro DF; Frishman WH
    South Med J; 2010 Jul; 103(7):669-73. PubMed ID: 20531060
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis: impact of drug class on adherence to antihypertensives.
    Kronish IM; Woodward M; Sergie Z; Ogedegbe G; Falzon L; Mann DM
    Circulation; 2011 Apr; 123(15):1611-21. PubMed ID: 21464050
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pharmacotherapy of Hypertension in Chronic Dialysis Patients.
    Georgianos PI; Agarwal R
    Clin J Am Soc Nephrol; 2016 Nov; 11(11):2062-2075. PubMed ID: 27797886
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
    Patel BV; Remigio-Baker RA; Mehta D; Thiebaud P; Frech-Tamas F; Preblick R
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
    [TBL] [Abstract][Full Text] [Related]  

  • 35. How well have practices followed guidelines in prescribing antihypertensive drugs: the role of health insurance.
    Guo JD; Liu GG; Christensen DB; Fu AZ
    Value Health; 2003; 6(1):18-28. PubMed ID: 12535235
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A meta-analytical approach to the efficacy of antihypertensive drugs in reducing blood pressure.
    Baguet JP; Robitail S; Boyer L; Debensason D; Auquier P
    Am J Cardiovasc Drugs; 2005; 5(2):131-40. PubMed ID: 15725044
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypertension: are beta-blockers and diuretics appropriate first-line therapies?
    Wilson MD; Weart CW
    Ann Pharmacother; 1994 May; 28(5):617-25. PubMed ID: 7915151
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Angiotensin converting enzyme inhibition in clinical practice. A re-examination of stepped-care: a retrospective and a prospective.
    Zanchetti A
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S126-31. PubMed ID: 2580166
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Management of hypertension in upheaval?].
    Zidek W; Paul M
    Dtsch Med Wochenschr; 2005 Nov; 130(46):2627. PubMed ID: 16281156
    [No Abstract]   [Full Text] [Related]  

  • 40. Selecting antihypertensive medication in patients with essential hypertension in Malaysia.
    Ong HT; Rozina G
    Med J Malaysia; 2009 Mar; 64(1):3-11. PubMed ID: 19852313
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.